RT Journal Article SR Electronic T1 Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy JF In Vivo JO In Vivo FD International Institute of Anticancer Research SP 1301 OP 1306 DO 10.21873/invivo.11603 VO 33 IS 4 A1 AKIO HIGUCHI A1 TORU AOYAMA A1 KEISUKE KAZAMA A1 MASAAKI MURAKAWA A1 YOSUKE ATSUMI A1 YUSUKE KATAYAMA A1 KOJI NUMATA A1 SHO SAWAZAKI A1 MASAKATSU NUMATA A1 SUMITO SATO A1 NOBUHIRO SUGANO A1 HIROSHI TAMAGAWA A1 HIROYUKI MUSHIAKE A1 TAKASHI OSHIMA A1 NORIO YUKAWA A1 SOICHIRO MORINAGA A1 YASUSHI RINO A1 MUNETAKA MASUDA A1 MANABU SHIOZAWA YR 2019 UL http://iv.iiarjournals.org/content/33/4/1301.abstract AB Background/Aim: We investigated the impact of Beppu's nomogram on colorectal liver metastasis in patients receiving perioperative chemotherapy and/or targeted therapy. Patients and Methods: This study included 43 patients who underwent primary hepatic resection for colorectal liver metastasis at the Kanagawa Cancer Center from June 2006 to March 2011. The patients were classified as having a Beppu's nomogram score ≤9 (low-risk group) or ≥10 (high-risk group). The risk factors for the disease-free survival (DFS) were identified. Results: The respective DFS rates at 1, 2, and 3 years after surgery were 72.0%, 43.3%, and 17.3% in the low-risk group and 27.8%, 16.7%, and 8.3% in the high-risk group, the difference being significant (p=0.009). The multivariate analysis showed that Beppu's nomogram score ≥10 was a significant independent risk factor for the DFS. Conclusion: Beppu's nomogram score was an independent prognostic factor for colorectal liver metastasis in patients receiving perioperative chemotherapy and/or targeted therapy. Thus, Beppu's nomogram might be a useful tool for predicting the risk of recurrence after hepatectomy, even in the era of newly-developed chemotherapy.